You are here: Home >Archive for March, 2010

Pharmaceutical Approval Update: Bupropion HCl XL (Wellbutrin XL)

Manufacturer: GlaxoSmithKline, Research Triangle Park, NC Indication: Generic Bupropion XL extended-release tablets are now approved to prevent major depressive episodes in adult patients with a history of seasonal affective disorder (SAD). Drug Class: This antidepressant of the amino ketone class is not chemically related to tricyclic and tetracyclic agents, selective serotonin reuptake inhibitors (SSRIs), or [...]

Tags: , ,

  • Digg
  • Del.icio.us
  • StumbleUpon
  • Reddit
  • Twitter

Pharmaceutical Approval Update

Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine (Gardasil) Manufacturer: Merck & Company, Whitehouse Station, NJ Indication: This vaccine is intended for the prevention of cervical cancer and genital warts (condyloma acuminata) caused by human papillomavirus (HPV) types 6, 11, 16, and 18, in girls and women nine to 26 years of age. [...]

Tags: , ,

  • Digg
  • Del.icio.us
  • StumbleUpon
  • Reddit
  • Twitter

Factors Associated with Epoetin Response: DISCUSSION

We found that the lower the baseline hemoglobin level, the more likely a patient was to respond to epoetin. It is possible that the patients with lower baseline hemoglobin levels had a greater degree of erythropoietin deficiency. Studies have shown that low baseline endogenous erythropoietin levels are associated with an epoetin response. However, endogenous erythropoietin [...]

Tags: ,

  • Digg
  • Del.icio.us
  • StumbleUpon
  • Reddit
  • Twitter

Factors Associated with Epoetin Response: RESULTS

Epoetin Response A total of 121 patients were included in the study. Seventy-two patients (60%) had anemia associated with CKD, and 49 patients (40%) had anemia associated with cancer. Forty-two patients (35%) were in the Responders group, and 79 patients (65%) were in the Nonresponders group. Baseline hemoglobin levels differed significantly between Responders (10 g/dl) [...]

Tags: ,

  • Digg
  • Del.icio.us
  • StumbleUpon
  • Reddit
  • Twitter

Factors Associated with Epoetin Response: METHODS

Retrospective chart reviews were conducted for all male patients who began epoetin therapy for anemia secondary to CKD or cancer between January 1, 2002, and December 31, 2003, at the Fargo VA Medical Center. Patients were excluded from the study if (1) they underwent a phlebotomy or multiple transfusions (i.e., on more than one occasion) [...]

Tags: ,

  • Digg
  • Del.icio.us
  • StumbleUpon
  • Reddit
  • Twitter

Factors Associated with Epoetin Response

INTRODUCTION Anemia frequently occurs in patients with chronic kidney disease (CKD) and in patients with cancer. In those with CKD, anemia is often the result of decreased erythropoietin production by the failing kidneys. Malignancy can lead to anemia because of the myelotoxic effects of chemotherapy and radiation treatments, as well as factors associated with the [...]

Tags: ,

  • Digg
  • Del.icio.us
  • StumbleUpon
  • Reddit
  • Twitter

Ephedrine and Epinephrine

Problem: The accidental administration of concentrated epinephrine is quite common. Many errors can be traced to confusion in expressing the concentration of epinephrine as a ratio strength rather than a metric weight per volume. However, confusion between epinephrine and ephedrine can also lead to errors.

Tags: ,

  • Digg
  • Del.icio.us
  • StumbleUpon
  • Reddit
  • Twitter
Pages: 1 2 3 Next